EPO906 Therapy

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EPO906 Therapy, covering 2012-04-17 to 2012-04-17. Get the full timeline:

Most recent: Clinical Trial Update: EPO906 Therapy in Patients With Advanced Kidney Cancer [Phase 2]